Galectin Therapeutics
GALT
#8189
Rank
S$0.22 B
Marketcap
$3.66
Share price
-3.37%
Change (1 day)
40.41%
Change (1 year)

Galectin Therapeutics (GALT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$0.14 Billion

According to Galectin Therapeutics's latest financial reports the company's total liabilities are S$0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$71.69 M35.25%
2021-12-31S$53 M641.07%
2020-12-31S$7.15 M84.74%
2019-12-31S$3.87 M34.45%
2018-12-31S$2.87 M-27.45%
2017-12-31S$3.96 M-27.44%
2016-12-31S$5.47 M184.38%
2015-12-31S$1.92 M-14.51%
2014-12-31S$2.25 M-28.56%
2013-12-31S$3.14 M56.67%
2012-12-31S$2.01 M-29.91%
2011-12-31S$2.86 M-72.14%
2010-12-31S$10.29 M49.6%
2009-12-31S$6.88 M310.33%
2008-12-31S$1.67 M-75.23%
2007-12-31S$6.77 M-30.83%
2006-12-31S$9.79 M326.11%
2005-12-31S$2.29 M40.14%
2004-12-31S$1.63 M155.29%
2003-12-31S$0.64 M-44.49%
2002-12-31S$1.15 M13.49%
2001-12-31S$1.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$0.24 B 66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.90 B 509.84%๐Ÿ‡บ๐Ÿ‡ธ USA